PACS vs. GH, OPCH, RDNT, BTSG, SHC, PRVA, CON, SGRY, ADUS, and VCYT
Should you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Addus HomeCare (ADUS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.
PACS Group vs. Its Competitors
Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.
92.6% of Guardant Health shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
PACS Group has higher revenue and earnings than Guardant Health.
In the previous week, Guardant Health had 4 more articles in the media than PACS Group. MarketBeat recorded 9 mentions for Guardant Health and 5 mentions for PACS Group. Guardant Health's average media sentiment score of 0.88 beat PACS Group's score of 0.38 indicating that Guardant Health is being referred to more favorably in the media.
Guardant Health has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Comparatively, PACS Group has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500.
Guardant Health currently has a consensus target price of $53.76, indicating a potential upside of 7.14%. PACS Group has a consensus target price of $34.29, indicating a potential upside of 162.32%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than Guardant Health.
PACS Group has a net margin of 0.00% compared to Guardant Health's net margin of -53.82%.
Summary
Guardant Health beats PACS Group on 8 of the 13 factors compared between the two stocks.
Get PACS Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PACS Group Competitors List
Related Companies and Tools
This page (NYSE:PACS) was last updated on 7/3/2025 by MarketBeat.com Staff
